Automated biochips that grow patients’ cancer cells outside the body, and test
the efficacy of different therapies
Encapsulate BioChip technology grows patient-derived cancer cells ex vivo, and screens them against chemotherapeutic drugs. With this technology the oncologist can choose the most effective chemotherapy drug prior to treatment on an individualized basis.
nCapsule grows the patient’s cancer cells as microtumors outside the body. and provides analytical insight to the oncologists on the patient’s response to the potential treatments.
nDoser grows our patented tumorlines and analyses the efficacy of a wide range of drug concentrations to minimize the required effective treatment doses to reduce the side effects of the chemotherapy.
Our automation tool, nCapsulizer, processes nCapsules, nDoser, and our other biochips, while creating a human body-like environment.
Media Coverage on Encapsulate Technology
Encapsulate LLC @ MassChallenge Boston